¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"ANT"¿¡ ´ëÇÑ Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú :
5
ÆäÀÌÁö:
7
ÄÚµå
¿µ¹®
ÇѱÛ
D80.6
Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia
°ÅÀÇ Á¤»óÀÇ ¸é¿ª±Û·ÎºÒ¸° ¶Ç´Â °í¸é¿ª±Û·ÎºÒ¸°Ç÷ÁõÀ» µ¿¹ÝÇÑ Ç×ü°áÇÌÁõ
Y51.0
Anticholinesterase agents
Ç×Äݸ°¿¡½ºÆ®¶óÁ¦Á¦
T44.0
Anticholinesterase agents
Ç×Äݸ°¿¡½ºÅÍ·¹À̽º ¾à¹°
Y44.3
Anticoagulant antagonists, vitamin K and other coagulants
Ç×ÀÀ°í¼º ´ëÇ×Á¦(±æÇ×Á¦), ºñŸ¹Î K ¹× ±âŸ ÀÀ°íÁ¦
T45.7
Anticoagulant antagonists, vitamin K and other coagulants
Ç×ÀÀ°í¼º ´ëÇ×Á¦(±æÇ×Á¦), ºñŸ¹ÎK ¹× ±âŸ ÀÀ°íÁ¦
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
7
ÄÚµå
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½